Literature DB >> 19864660

Risk factors for progressive supranuclear palsy: a case-control study in France.

J-S Vidal1, M Vidailhet, P Derkinderen, T Dubard de Gaillarbois, C Tzourio, A Alpérovitch.   

Abstract

BACKGROUND: The risk factors of progressive supranuclear palsy (PSP), a rare but severe Parkinsonian syndrome, are poorly known.
OBJECTIVE: To study the risk factors of PSP in a case control study among French patients.
METHOD: The study was conducted between April 2000 and December 2003. Cases were in- or outpatients of five large hospitals and fulfilled the Golbe criteria. Controls were relatives of patients from the same hospitals, free of Parkinsonian syndrome and dementia, and matched to cases for age, gender and living area. Data on demographic characteristics, occupation history, diet habits, anti-inflammatory drugs use, alcohol consumption, smoking habits, gardening and leisure activities, and exposure to pesticides were collected through a face-to-face questionnaire. A conditional logistic regression was used to analyse matched data and estimate OR.
RESULTS: 79 cases and 79 controls were included. Only a few comparisons were significant. Cases reached a lower education attainment than controls (odds ratio (OR) = 2.6 (1.3 to 5.3), p = 0.01). Analysis of diet habits did not show any major difference although cases ate meat or poultry more frequently. Conversely, controls ate fruits more frequently than did cases. No association was found between PSP and occupation, use of pesticides, gardening, alcohol consumption, smoking habits and anti-inflammatory agent use.
CONCLUSION: In this case-control study, we did not find any strong environmental risk factors for PSP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864660     DOI: 10.1136/jnnp.2008.149849

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

1.  Familial aggregation in atypical Parkinson's disease: a case control study in multiple system atrophy and progressive supranuclear palsy.

Authors:  Jean-Sébastien Vidal; Marie Vidailhet; Pascal Derkinderen; Christophe Tzourio; Annick Alpérovitch
Journal:  J Neurol       Date:  2010-07-13       Impact factor: 4.849

2.  A geographical cluster of progressive supranuclear palsy in northern France.

Authors:  Dominique Caparros-Lefebvre; Lawrence I Golbe; Vincent Deramecourt; Claude-Alain Maurage; Vincent Huin; Valerie Buée-Scherrer; Helene Obriot; Bernard Sablonnière; Francois Caparros; Luc Buée; Andrew J Lees
Journal:  Neurology       Date:  2015-09-09       Impact factor: 9.910

3.  Smoking cessation for the neurologic patient.

Authors:  Jinny Tavee
Journal:  Neurol Clin Pract       Date:  2012-06

4.  Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study.

Authors:  Irene Litvan; Peter S J Lees; Christopher R Cunningham; Shesh N Rai; Alexander C Cambon; David G Standaert; Connie Marras; Jorge Juncos; David Riley; Stephen Reich; Deborah Hall; Benzi Kluger; Yvette Bordelon; David R Shprecher
Journal:  Mov Disord       Date:  2016-02-08       Impact factor: 10.338

5.  Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans.

Authors:  Kristen D Kelley; Harvey Checkoway; Deborah A Hall; Stephen G Reich; Chris Cunningham; Irene Litvan
Journal:  Front Neurol       Date:  2018-06-20       Impact factor: 4.003

Review 6.  Frontrunner in Translation: Progressive Supranuclear Palsy.

Authors:  Ali Shoeibi; Nahid Olfati; Irene Litvan
Journal:  Front Neurol       Date:  2019-10-22       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.